E. Coli Methods and Protocols M E T H O D S I N M O L E C U L a R B I O L O G Y

Total Page:16

File Type:pdf, Size:1020Kb

E. Coli Methods and Protocols M E T H O D S I N M O L E C U L a R B I O L O G Y UC Irvine UC Irvine Previously Published Works Title Protein Folding Using a Vortex Fluidic Device. Permalink https://escholarship.org/uc/item/2bb550m5 Journal Methods in molecular biology (Clifton, N.J.), 1586 ISSN 1064-3745 Authors Britton, Joshua Smith, Joshua N Raston, Colin L et al. Publication Date 2017 DOI 10.1007/978-1-4939-6887-9_13 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Methods in Molecular Biology 1586 Nicola A. Burgess-Brown Editor Heterologous Gene Expression in E. coli Methods and Protocols M ETHODS IN M OLECULAR B IOLOGY Series Editor John M. Walker School of Life and Medical Sciences University of Hertfordshire Hatfield, Hertfordshire, AL10 9AB, UK For further volumes: http://www.springer.com/series/7651 Heterologous Gene Expression in E. coli Methods and Protocols Edited by Nicola A. Burgess-Brown SGC, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK Editor Nicola A. Burgess-Brown SGC Nuffield Department of Clinical Medicine University of Oxford Oxford, UK ISSN 1064-3745 ISSN 1940-6029 (electronic) Methods in Molecular Biology ISBN 978-1-4939-6885-5 ISBN 978-1-4939-6887-9 (eBook) DOI 10.1007/978-1-4939-6887-9 Library of Congress Control Number: 2017934051 © Springer Science+Business Media LLC 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Humana Press imprint is published by Springer Nature The registered company is Springer Science+Business Media LLC The registered company address is: 233 Spring Street, New York, NY 10013, U.S.A. Preface Heterologous gene expression in E. coli has been one of the most widely used methods for generating recombinant proteins for many scientific analyses and still remains the first choice for most laboratories around the world. The ease of use and low cost of production often lead researchers to initially attempt to express their proteins of interest in E. coli rather than opting for a eukaryotic host. Decades of development have seen the variety of methods for expressing genes in E. coli broaden, with improved media and optimized conditions for growth, a choice of promoter systems to regulate expression, fusion tags to aid solubility and purification, and E. coli host strains to accommodate more challenging or toxic proteins. Having worked in the area of protein production for structural genomics for the past 12 years, and also having a requirement to generate human proteins, I have seen a shift from expression of many genes in E. coli to use of the baculovirus expression system using insect cells and more recently to mammalian cells. This revolution from prokaryotic to eukaryotic expression has been visible throughout the protein production field and is largely due to the requirement to obtain specific proteins linked to disease, for functional assays as well as structures, which may be larger, or require machinery to enable specific post-­ translational modifications. It is perhaps important to note, however, that the structural output from the SGC in Oxford today is still ~80% derived from E. coli. This book is aimed at molecular biologists, biochemists, and structural biologists, both from the beginning of their research careers to those in their prime, to give both an historical and modern overview of the methods available to express their genes of interest in this exceptional organism. The topics are largely grouped under four parts: (I) high- throughput cloning, expression screening, and optimization of expression conditions, (II) protein production and solubility enhancement, (III) case studies to produce challenging proteins and specific protein families, and (IV) applications of E. coli expression. This vol- ume provides scientists with a toolbox for designing constructs, tackling expression and solubility issues, handling membrane proteins and protein complexes, and innovative engineering of E. coli. It will hopefully prove valuable both in small laboratories and in higher throughput facilities. I would like to thank all the authors for their contributions and for making this a global effort. Oxford, UK Nicola A. Burgess-Brown v Contents Preface . v Contributors . xi PART I HiGh-ThROUGhpUT CLONiNG, EXpReSSiON ScReeNiNG, AND OpTiMiZATiON 1 Recombinant Protein Expression in E. coli: A Historical Perspective . 3 Opher Gileadi 2 N- and C-Terminal Truncations to Enhance Protein Solubility and Crystallization: Predicting Protein Domain Boundaries with Bioinformatics Tools . 11 Christopher D.O. Cooper and Brian D. Marsden 3 Harnessing the Profinity eXact™ System for Expression and Purification of Heterologous Proteins in E. coli . 33 Yoav Peleg, Vadivel Prabahar, Dominika Bednarczyk, and Tamar Unger 4 ESPRIT: A Method for Defining Soluble Expression Constructs in Poorly Understood Gene Sequences . 45 Philippe J. Mas and Darren J. Hart 5 Optimizing Expression and Solubility of Proteins in E. coli Using Modified Media and Induction Parameters . 65 Troy Taylor, John-Paul Denson, and Dominic Esposito 6 Optimization of Membrane Protein Production Using Titratable Strains of E. coli . 83 Rosa Morra, Kate Young, David Casas-Mao, Neil Dixon, and Louise E. Bird 7 Optimizing E. coli-Based Membrane Protein Production Using Lemo21(DE3) or pReX and GFP-Fusions . 109 Grietje Kuipers, Markus Peschke, Nurzian Bernsel Ismail, Anna Hjelm, Susan Schlegel, David Vikström, Joen Luirink, and Jan-Willem de Gier 8 High Yield of Recombinant Protein in Shaken E. coli Cultures with Enzymatic Glucose Release Medium EnPresso B . 127 Kaisa Ukkonen, Antje Neubauer, Vinit J. Pereira, and Antti Vasala PART II PROTeiN PURiFicATiON AND SOLUBiLiTY ENhANceMeNT 9 A Generic Protocol for Purifying Disulfide-Bonded Domains and Random Protein Fragments Using Fusion Proteins with SUMO3 and Cleavage by SenP2 Protease . 141 Hüseyin Besir vii viii Contents 10 A Strategy for Production of Correctly Folded Disulfide-Rich Peptides in the Periplasm of E. coli . 155 Natalie J. Saez, Ben Cristofori-Armstrong, Raveendra Anangi, and Glenn F. King 11 Split GFP Complementation as Reporter of Membrane Protein Expression and Stability in E. coli : A Tool to Engineer Stability in a LAT Transporter . 181 Ekaitz Errasti-Murugarren, Arturo Rodríguez-Banqueri, and José Luis Vázquez-Ibar 12 Acting on Folding Effectors to Improve Recombinant Protein Yields and Functional Quality . 197 Ario de Marco 13 Protein Folding Using a Vortex Fluidic Device . 211 Joshua Britton, Joshua N. Smith, Colin L. Raston, and Gregory A. Weiss 14 Removal of Affinity Tags with TEV Protease . 221 Sreejith Raran-Kurussi, Scott Cherry, Di Zhang, and David S. Waugh PART III CASe STUDieS TO PRODUce ChALLeNGiNG PROTeiNS AND SpeciFic PROTeiN FAMiLieS 15 Generation of Recombinant N-Linked Glycoproteins in E. coli . 233 Benjamin Strutton, Stephen R.P. Jaffé, Jagroop Pandhal, and Phillip C. Wright 16 Production of Protein Kinases in E. coli . 251 Charlotte A. Dodson 17 Expression of Prokaryotic Integral Membrane Proteins in E. coli . 265 James D. Love 18 Multiprotein Complex Production in E. coli: The SecYEG-­SecDFYajC-­YidC Holotranslocon . 279 Imre Berger, Quiyang Jiang, Ryan J. Schulze, Ian Collinson, and Christiane Schaffitzel 19 Membrane Protein Production in E. coli Lysates in Presence of Preassembled Nanodiscs . 291 Ralf-Bernhardt Rues, Alexander Gräwe, Erik Henrich, and Frank Bernhard 20 Not Limited to E. coli: Versatile Expression Vectors for Mammalian Protein Expression . 313 Katharina Karste, Maren Bleckmann, and Joop van den Heuvel 21 A Generic Protocol for Intracellular Expression of Recombinant Proteins in Bacillus subtilis . 325 Trang Phan, Phuong Huynh, Tuom Truong, and Hoang Nguyen PART IV AppLicATiONS OF E. COLI EXpReSSiON 22 In Vivo Biotinylation of Antigens in E. coli . 337 Susanne Gräslund, Pavel Savitsky, and Susanne Müller-Knapp Contents ix 23 Cold-Shock Expression System in E. coli for Protein NMR Studies . 345 Toshihiko Sugiki, Toshimichi Fujiwara, and Chojiro Kojima 24 High-Throughput Production of Proteins in E. coli for Structural Studies . 359 Charikleia Black, John J. Barker, Richard B. Hitchman, Hok Sau Kwong, Sam Festenstein, and Thomas B. Acton 25 Mass Spectrometric Analysis of Proteins . 373 Rod Chalk 26 How to Determine Interdependencies of Glucose and Lactose Uptake Rates for Heterologous Protein
Recommended publications
  • Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
    toxins Review Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease Rosalia Marcano 1, M. Ángeles Rojo 2 , Damián Cordoba-Diaz 3 and Manuel Garrosa 1,* 1 Department of Cell Biology, Histology and Pharmacology, Faculty of Medicine and INCYL, University of Valladolid, 47005 Valladolid, Spain; [email protected] 2 Area of Experimental Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain; [email protected] 3 Area of Pharmaceutics and Food Technology, Faculty of Pharmacy, and IUFI, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Abstract: It is widely recognized that periodontal disease is an inflammatory entity of infectious origin, in which the immune activation of the host leads to the destruction of the supporting tissues of the tooth. Periodontal pathogenic bacteria like Porphyromonas gingivalis, that belongs to the complex net of oral microflora, exhibits a toxicogenic potential by releasing endotoxins, which are the lipopolysaccharide component (LPS) available in the outer cell wall of Gram-negative bacteria. Endotoxins are released into the tissues causing damage after the cell is lysed. There are three well-defined regions in the LPS: one of them, the lipid A, has a lipidic nature, and the other two, the Core and the O-antigen, have a glycosidic nature, all of them with independent and synergistic functions. Lipid A is the “bioactive center” of LPS, responsible for its toxicity, and shows great variability along bacteria. In general, endotoxins have specific receptors at the cells, causing a wide immunoinflammatory response by inducing the release of pro-inflammatory cytokines and the production of matrix metalloproteinases.
    [Show full text]
  • Fall Fiber Festival 2019 Schedule of Events
    Fall Fiber Festival 2019 Schedule of Events Ongoing Activities Saturday and Sunday Montpelier Sheep Dog Trials, sponsored by the VA Border Collie Association Skein, Garment & Fiber Arts Competition and Display - Display & Demo Tent Fiber Arts Demonstrations and Hands-on Activities - Display & Demo Tent Fleece Sale - Fleece Sale Tent Saturday October 5, 2019, 10 am – 5 pm ALL DAY Weaving & Spinning Demos, Fiber Prep & Combing, Knit/Crochet Help, Circular Sock Knitting Machines, Yarn/Ball Winding ~ Display & Demo Tent 9:30 am-4:30 pm FELTING WORKSHOP: Felted Necklace ~ Workshop Tents 9:30 am-12:30 pm SPINNING WORKSHOP: Interaction of Color in Spinning ~ Workshop Tents 10 am-4 pm FACE PAINTING ~ Near Animal Exhibit Tent 10 am-4:30 pm DEMO: Circular Sock Knitting Machines ~ Display & Demo Tent 10 am-4:30 pm DEMO: Spinning from a Bunny ~ Display & Demo Tent 10 am-Noon DEMO: Knitting on a Knitting Machine ~ Display & Demo Tent 10 am-11am DEMO: Spinning Shetland Fleece ~ Display & Demo Tent 10:30 am-Noon DEMO: Embroidery & Stitching ~ Display & Demo Tent 11:00 am SHEEP SHEARING ~ Animal Exhibit Tent 11 am-1 pm DEMO: Great Wheel Spinning (Weather Permitting) ~ Display & Demo Tent 11 am-Noon DEMO: Combing Wool for Worsted Spinning ~ Display & Demo Tent 11 am-1 pm DEMO: Nuno Felting ~ Display & Demo Tent 12:30 pm-2 pm DEMO: Tri-Loom Weaving ~ Display & Demo Tent 1 pm-4 pm DEMO: Needle Felted Flowers - Ginter Garden Felters ~ Display & Demo Tent 1 pm-2:30 pm DEMO: Kumihimo Braiding ~ Display & Demo Tent 1 pm-2 pm KIDS CLASS: Walk in Projects for
    [Show full text]
  • Methylase-Assisted Subcloning for High Throughput Biobrick Assembly
    Methylase-assisted subcloning for high throughput BioBrick assembly Ichiro Matsumura Emory University School of Medicine, Department of Biochemistry, Atlanta, GA, United States of America ABSTRACT The BioBrick standard makes possible iterated pairwise assembly of cloned parts with- out any depletion of unique restriction sites. Every part that conforms to the standard is compatible with every other part, thereby fostering a worldwide user community. The assembly methods, however, are labor intensive or inefficient compared to some newer ones so the standard may be falling out of favor. An easier way to assemble BioBricks is described herein. Plasmids encoding BioBrick parts are purified from Escherichia coli cells that express a foreign site-specific DNA methyltransferase, so that each is subsequently protected in vitro from the activity of a particular restriction endonuclease. Each plasmid is double-digested and all resulting restriction fragments are ligated together without gel purification. The ligation products are subsequently double-digested with another pair of restriction endonucleases so only the desired insert-recipient vector construct retains the capacity to transform E. coli. This 4R/2M BioBrick assembly protocol is more efficient and accurate than established workflows including 3A assembly. It is also much easier than gel purification to miniaturize, automate and perform more assembly reactions in parallel. As such, it should streamline DNA assembly for the existing community of BioBrick users, and possibly encourage others to join. Subjects Bioengineering, Molecular Biology, Synthetic Biology Keywords BioBrick assembly, Methylase-assisted cloning, Synthetic biology, Laboratory automation, DNA methyltransferase Submitted 27 April 2020 Accepted 10 August 2020 Published 11 September 2020 INTRODUCTION Corresponding author A bottleneck in many synthetic biology projects is the physical linkage of cloned synthetic Ichiro Matsumura, [email protected] genes (``parts'') to each other to form longer functional assemblies (``devices'').
    [Show full text]
  • Solutions for Practice Problems for Molecular Biology, Session 5
    Solutions to Practice Problems for Molecular Biology, Session 5: Gene Regulation and the Lac Operon Question 1 a) How does lactose (allolactose) promote transcription of LacZ? 1) Lactose binds to the polymerase and increases efficiency. 2) Lactose binds to a repressor protein, and alters its conformation to prevent it from binding to the DNA and interfering with the binding of RNA polymerase. 3) Lactose binds to an activator protein, which can then help the RNA polymerase bind to the promoter and begin transcription. 4) Lactose prevents premature termination of transcription by directly binding to and bending the DNA. Solution: 2) Lactose binds to a repressor protein, and alters its conformation to prevent it from binding to the DNA and interfering with the binding of RNA polymerase. b) What molecule is used to signal low glucose levels to the Lac operon regulatory system? 1) Cyclic AMP 2) Calcium 3) Lactose 4) Pyruvate Solution: 1) Cyclic AMP. Question 2 You design a summer class where you recreate experiments studying the lac operon in E. coli (see schematic below). In your experiments, the activity of the enzyme b-galactosidase (β -gal) is measured by including X-gal and IPTG in the growth media. X-gal is a lactose analog that turns blue when metabolisize by b-gal, but it does not induce the lac operon. IPTG is an inducer of the lac operon but is not metabolized by b-gal. I O lacZ Plac Binding site for CAP Pi Gene encoding β-gal Promoter for activator protein Repressor (I) a) Which of the following would you expect to bind to β-galactosidase? Circle all that apply.
    [Show full text]
  • Instability of Toxin a Subunit of AB5 Toxins in the Bacterial Periplasm Caused by Deficiency of Their Cognate B Subunits
    Biochimica et Biophysica Acta 1808 (2011) 2359–2365 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamem Instability of toxin A subunit of AB5 toxins in the bacterial periplasm caused by deficiency of their cognate B subunits Sang-Hyun Kim a, Su Hyang Ryu a, Sang-Ho Lee a, Yong-Hoon Lee a, Sang-Rae Lee a, Jae-Won Huh a, Sun-Uk Kim a, Ekyune Kim d, Sunghyun Kim b, Sangyong Jon b, Russell E. Bishop c,⁎, Kyu-Tae Chang a,⁎⁎ a The National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Chungbuk 363–883, Republic of Korea b School of Life Science, Gwangju Institute of Science and Technology (GIST), 1 Oryong-dong, Gwangju 500–712, Republic of Korea c Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5 d College of Pharmacy, Catholic University of Daegu, Hayang-eup, Gyeongsan, Gyeongbuk 712-702, Republic of Korea article info abstract Article history: Shiga toxin (STx) belongs to the AB5 toxin family and is transiently localized in the periplasm before secretion Received 26 April 2011 into the extracellular milieu. While producing outer membrane vesicles (OMVs) containing only A subunit of Received in revised form 3 June 2011 the toxin (STxA), we created specific STx1B- and STx2B-deficient mutants of E. coli O157:H7. Surprisingly, Accepted 23 June 2011 STxA subunit was absent in the OMVs and periplasm of the STxB-deficient mutants. In parallel, the A subunit Available online 5 July 2011 of heat-labile toxin (LT) of enterotoxigenic E.
    [Show full text]
  • Mycotoxin Analysis in Infant Formula Using Captiva EMR-Lipid
    Application Note Food Testing & Agriculture Mycotoxin Analysis in Infant Formula Using Captiva EMR—Lipid Cleanup and LC/MS/MS Author Abstract Derick Lucas Agilent Technologies, Inc. Several countries regulate the levels of mycotoxins in foods. However, the complexity of certain foodstuffs in terms of protein and lipid content can prove challenging in the accurate quantitation of low-level mycotoxins in these matrices. This Application Note describes the determination of 13 multiclass mycotoxins in solid and liquid infant formulations using a Quick Easy Cheap Effective Rugged Safe (QuEChERS) workflow followed by Agilent Captiva EMR—Lipid cartridge cleanup. Due to the high selectivity of the Captiva EMR—Lipid sorbent, excellent recoveries (70.4 to 106.8 %) and precision (<18 %) were achieved for all mycotoxins. This simple and robust methodology requires minimal equipment and expertise, which promotes easy implementation in food laboratories. Introduction Experimental Mycotoxins are produced as secondary metabolites by fungal Sample preparation species that grow on various crops such as grain, corn, and • Captiva EMR—Lipid 3-mL tubes (p/n 5190-1003) nuts. When cows ingest contaminated feed, mycotoxins and their metabolites can be excreted into the animal’s milk1. • Captiva EMR—Lipid 6-mL tubes (p/n 5190-1004) Aflatoxin M1 is the most commonly found mycotoxin in milk, • QuEChERS original extraction salts (p/n 5982-5550) and is monitored and regulated in many countries, including • VacElut SPS 24 vacuum manifold (p/n 12234022) the United States and European countries2,3. Despite a lack of regulations for other mycotoxins in milk, there is a growing LC configuration and parameters interest to monitor additional mycotoxins such as fumonisins and ochratoxins.
    [Show full text]
  • The Lactose Operon from Lactobacillus Casei Is Involved in the Transport
    www.nature.com/scientificreports OPEN The lactose operon from Lactobacillus casei is involved in the transport and metabolism of the Received: 4 October 2017 Accepted: 26 April 2018 human milk oligosaccharide core-2 Published: xx xx xxxx N-acetyllactosamine Gonzalo N. Bidart1, Jesús Rodríguez-Díaz 2, Gaspar Pérez-Martínez1 & María J. Yebra1 The lactose operon (lacTEGF) from Lactobacillus casei strain BL23 has been previously studied. The lacT gene codes for a transcriptional antiterminator, lacE and lacF for the lactose-specifc phosphoenolpyruvate: phosphotransferase system (PTSLac) EIICB and EIIA domains, respectively, and lacG for the phospho-β-galactosidase. In this work, we have shown that L. casei is able to metabolize N-acetyllactosamine (LacNAc), a disaccharide present at human milk and intestinal mucosa. The mutant strains BL153 (lacE) and BL155 (lacF) were defective in LacNAc utilization, indicating that the EIICB and EIIA of the PTSLac are involved in the uptake of LacNAc in addition to lactose. Inactivation of lacG abolishes the growth of L. casei in both disaccharides and analysis of LacG activity showed a high selectivity toward phosphorylated compounds, suggesting that LacG is necessary for the hydrolysis of the intracellular phosphorylated lactose and LacNAc. L. casei (lacAB) strain defcient in galactose-6P isomerase showed a growth rate in lactose (0.0293 ± 0.0014 h−1) and in LacNAc (0.0307 ± 0.0009 h−1) signifcantly lower than the wild-type (0.1010 ± 0.0006 h−1 and 0.0522 ± 0.0005 h−1, respectively), indicating that their galactose moiety is catabolized through the tagatose-6P pathway. Transcriptional analysis showed induction levels of the lac genes ranged from 130 to 320–fold in LacNAc and from 100 to 200–fold in lactose, compared to cells growing in glucose.
    [Show full text]
  • Impact of Bacterial Toxins in the Lungs
    toxins Review Impact of Bacterial Toxins in the Lungs 1,2,3, , 4,5, 3 2 Rudolf Lucas * y, Yalda Hadizamani y, Joyce Gonzales , Boris Gorshkov , Thomas Bodmer 6, Yves Berthiaume 7, Ueli Moehrlen 8, Hartmut Lode 9, Hanno Huwer 10, Martina Hudel 11, Mobarak Abu Mraheil 11, Haroldo Alfredo Flores Toque 1,2, 11 4,5,12,13, , Trinad Chakraborty and Jürg Hamacher * y 1 Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; hfl[email protected] 2 Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 3 Department of Medicine and Division of Pulmonary Critical Care Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 4 Lungen-und Atmungsstiftung, Bern, 3012 Bern, Switzerland; [email protected] 5 Pneumology, Clinic for General Internal Medicine, Lindenhofspital Bern, 3012 Bern, Switzerland 6 Labormedizinisches Zentrum Dr. Risch, Waldeggstr. 37 CH-3097 Liebefeld, Switzerland; [email protected] 7 Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada; [email protected] 8 Pediatric Surgery, University Children’s Hospital, Zürich, Steinwiesstrasse 75, CH-8032 Zürch, Switzerland; [email protected] 9 Insitut für klinische Pharmakologie, Charité, Universitätsklinikum Berlin, Reichsstrasse 2, D-14052 Berlin, Germany; [email protected] 10 Department of Cardiothoracic Surgery, Voelklingen Heart Center, 66333
    [Show full text]
  • Lucet Braiding
    Lucet Braiding A lucet is a simple 2 pronged device used during the Middle Ages (and earlier and later) for making cords. It is most often associated with the Viking Era but were used through out Europe. It makes a strong either square or flat cord. Lucets were made of horn, bone or wood. The cords, also called chains, were used as drawstrings in clothing and bags or purses. They were also used ornamentally as trim on clothing and other items and to hang items from belts. Larger versions of these cords were probably also used by sailors. Making Your Own Lucet A lucet can be made from any 2 pronged item. My first lucet was a plastic 2 pronged fork. My second lucet was a large wooden fork with the center prongs removed. The lyre shape can be cut out of 1/4 inch wood such as pine or oak and then the edges sanded. Basic Square Cord Crochet thread or thin yarn is good for beginners to start with. 1. Drop a 6 inch tail of the thread through the hole going from front to back. If your lucet doesn't have a hole, it is not a problem, just pull the tail around to the back of the lucet. 2. Holding the lucet in your left hand with the thumb holding the tail in place above the hole, wind the thread as shown: front to back on the right arm, then front to back on the left arm and then front to back on the right arm again, making a "figure 8." The thread should now be on teh back side where you can hold it between two fingers to keep it snug around the arms.
    [Show full text]
  • A New Biobrick Assembly Strategy Designed for Facile Protein Engineering
    A New Biobrick Assembly Strategy Designed for Facile Protein Engineering Ira E. Phillips∗ and Pamela A. Silver∗ April 18, 2006 Abstract The existing biobrick assembly technique[1] provides a straightforward way to combine standardized biological components, termed biobricks. This system, however, is limited in that each protein-encoding biobrick must contain a complete translated region. Signal sequences or other pro- tein domains often convey a specific function to the protein to which they are attached; hence, each domain should be considered an independent biological part. With the current assembly technique, assembling such parts is not possible. This paper presents a revised assembly strategy that is compatible with the current biobrick definition and permits the construction of fusion proteins. Introduction The standard biobrick assembly technique was created in an attempt to simplify the construction of long concatemeric pieces of DNA often used in synthetic biology [1]. Previously existing techniques were limiting in that one often needed to design a unique cloning strategy for each desired construct. Moreover, the intermediates in the cloning of one construct would be of little value in creating other constructs. As a solution to these problems, T. Knight developed a novel cloning strategy that permits standardization of biological parts or biobricks [1]. Each biobrick can be placed in front of or behind another biobrick using a standard protocol that is independent of the content of the parts involved. (To insert a biobrick in front of another, simply digest the upstream biobrick with EcoRI and SpeI. Cut out this insert and ligate into a vector containing the second part cut with EcoRI and XbaI.
    [Show full text]
  • Area # 1 Area #2
    Area # 1 Black Sheep Handweavers Guild 2-Clip Fringe Twister Knit Wits Kit for Making a Stuffed Penguin, including the Double Point Needles 3 Skeins of Yarn Glenna Harris Weavers’ Guild 1 Boat shuttle 1 Heddle maker 4 Balls Boucle’ Yarn, Beige 1) 1 oz. Bag of White Corriedale Roving 5 Bags Multicolor Roving, from 1 oz. - 5 ozs. Carmel Crafts Guild Harrisville Design Boat Shuttle 6 Wooden Bobbins Area #2 Del Oro Spinners & Weavers Guild Assorted yarns Bucilla Spice, 14) 1.75 oz. Skeins Bernat Fabri, 5) 2 oz. Skeins (600 yds. Ea.) 4 Burgundy, 1 Grey Peaches and Cream - 1 lb. Cone 4 Ply Cotton (Emerald Forest) Knitting Books - H ip to K n it by Judith Swartz & Tops to Toes edited by Kara Gott Warner Whole Rambouillet/Cormo fleece (unwashed) 6.5 pounds, 3.5" to 4" Staple Length Golden Valley Weavers and Spinnters 2 DVD’s - A rtists G u ide to Color an d D ou blew eave P ick u p Mother Lode Weavers and Spinners Our fiber basket is almost exclusively filled with fiber donated by fiber ranchers in Tuolumne and Calaveras Counties. The MLW&S Guild is fortunate to include a versatile range of fiber artists & ranchers. We wish to take this opportunity to thank all of our vendors for their generous donations to this basket. The fiber basket also includes a book, written and donated by Peggy Huth, about a little sheep named Bummer (a true story). The book is a sweet story with heartfelt illustrations that will delight children of all ages.
    [Show full text]
  • Host-Based Lipid Inflammation Drives Pathogenesis in Francisella Infection
    Host-based lipid inflammation drives pathogenesis in Francisella infection Alison J. Scotta, Julia Maria Postb, Raissa Lernerb, Shane R. Ellisc, Joshua Liebermand, Kari Ann Shireye, Ron M. A. Heerenc, Laura Bindilab, and Robert K. Ernsta,1 aDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD 21201; bLaboratory for Eicosanoids and Endocannabinoids, Johannes Gutenberg University Mainz, 55099 Mainz, Germany; cMaastricht MultiModal Molecular Imaging Institute, Maastricht University, 6229 ER Maastricht, The Netherlands; dDepartment of Pathology, University of Washington Medical Center, Seattle, WA 98118; and eDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD 21201 Edited by Roy Curtiss III, University of Florida, Gainesville, FL, and approved October 16, 2017 (received for review July 19, 2017) Mass spectrometry imaging (MSI) was used to elucidate host lipids MSI (18), although other ionization methods [such as desorption involved in the inflammatory signaling pathway generated at the electrospray ionization (DESI) and liquid extraction surface host–pathogen interface during a septic bacterial infection. Using analysis (LESA), and others] are also employed. MSI has been Francisella novicida as a model organism, a bacterial lipid virulence used in a wide array of applications ranging from fingerprint factor (endotoxin) was imaged and identified along with host phos- analysis to mapping drug distribution in tissue. MSI studies of pholipids involved in the splenic response in murine tissues. Here, cancer biology for biomarker discovery, therapeutic target iden- we demonstrate detection and distribution of endotoxin in a lethal tification, and fundamental pathology hold particular promise. In murine F. novicida infection model, in addition to determining the contrast, comparatively few systematic studies have leveraged MSI – temporally and spatially resolved innate lipid inflammatory response to describe the host microbe relationship (19, 20).
    [Show full text]